Fulcrum Therapeutics
FULC
FULC
130 hedge funds and large institutions have $196M invested in Fulcrum Therapeutics in 2024 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 32 increasing their positions, 35 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 35
16.27% less ownership
Funds ownership: 104.28% → 88.01% (-16%)
51% less capital invested
Capital invested by funds: $402M → $196M (-$206M)
Holders
130
Holding in Top 10
2
Calls
$25.5M
Puts
$7.19M
Top Buyers
| 1 | +$18.7M | |
| 2 | +$17.1M | |
| 3 | +$6.07M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$3.82M |
| 5 |
BlackRock
New York
|
+$3.24M |
Top Sellers
| 1 | -$36.2M | |
| 2 | -$18.4M | |
| 3 | -$12.9M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$8.96M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$8.89M |